{"id":"https://openalex.org/W194829289","doi":null,"title":"Quality improvement in the continuum of care: impact of atherothrombosis in managed care pharmacy.","display_name":"Quality improvement in the continuum of care: impact of atherothrombosis in managed care pharmacy.","publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W194829289","mag":"194829289","pmid":"https://pubmed.ncbi.nlm.nih.gov/15546222"},"language":"en","primary_location":{"id":"pmid:15546222","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15546222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of managed care pharmacy : JMCP","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009464151","display_name":"Michael Toscani","orcid":"https://orcid.org/0000-0003-3003-7931","observed_orcids":["https://orcid.org/0000-0003-3003-7931"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R Toscani","raw_affiliation_strings":["Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, USA. mt1057@aol.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, USA. mt1057@aol.com","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109070887","display_name":"Rajendra R. Makkar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajendra Makkar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5050862786","display_name":"Michael B. Bottorff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael B Bottorff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"10","issue":"6 Suppl A","first_page":"S2","last_page":"12; quiz S13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.7314000129699707,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.7314000129699707,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.050700001418590546,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.0502999983727932,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atherothrombosis","display_name":"atherothrombosis","score":1.0},{"id":"https://openalex.org/keywords/quality-improvement","display_name":"quality improvement","score":0.6729999780654907},{"id":"https://openalex.org/keywords/managed-care-pharmacy","display_name":"managed care pharmacy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/disease-management-programs","display_name":"disease management programs","score":0.9760000109672546},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.4950000047683716},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.6809999942779541},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6349999904632568},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9432240724563599},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.7519437074661255},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.6569074392318726},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.5953407287597656},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5317921042442322},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5184523463249207},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.49108076095581055},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.470990389585495},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4343947470188141},{"id":"https://openalex.org/C2982889124","wikidata":"https://www.wikidata.org/wiki/Q107439039","display_name":"Disease management","level":4,"score":0.42401599884033203},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.18115922808647156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17396733164787292},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.1331987977027893},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.13252177834510803},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003266","descriptor_name":"Continuity of Patient Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008329","descriptor_name":"Managed Care Programs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011785","descriptor_name":"Quality Assurance, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019468","descriptor_name":"Disease Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:15546222","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15546222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of managed care pharmacy : JMCP","raw_type":"Journal Article"},{"id":"mag:194829289","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15546222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W55094036","https://openalex.org/W105318348","https://openalex.org/W1553345686","https://openalex.org/W1906583378","https://openalex.org/W1968282828","https://openalex.org/W1977155256","https://openalex.org/W1977504640","https://openalex.org/W1978036628","https://openalex.org/W1979346069","https://openalex.org/W2000634649","https://openalex.org/W2002269945","https://openalex.org/W2006054403","https://openalex.org/W2011847848","https://openalex.org/W2017842679","https://openalex.org/W2019699143","https://openalex.org/W2027538725","https://openalex.org/W2030189178","https://openalex.org/W2034450617","https://openalex.org/W2037360592","https://openalex.org/W2052875111","https://openalex.org/W2053379248","https://openalex.org/W2056999691","https://openalex.org/W2069349973","https://openalex.org/W2070892802","https://openalex.org/W2078300579","https://openalex.org/W2089508937","https://openalex.org/W2093064246","https://openalex.org/W2099961758","https://openalex.org/W2104964350","https://openalex.org/W2105872403","https://openalex.org/W2106775861","https://openalex.org/W2114041950","https://openalex.org/W2120335639","https://openalex.org/W2124242147","https://openalex.org/W2127489984","https://openalex.org/W2135406252","https://openalex.org/W2137835206","https://openalex.org/W2140136269","https://openalex.org/W2143004627","https://openalex.org/W2148847525","https://openalex.org/W2160613916","https://openalex.org/W2167328026","https://openalex.org/W2170218245","https://openalex.org/W2315630371","https://openalex.org/W2331274940","https://openalex.org/W2407674438","https://openalex.org/W2461891299","https://openalex.org/W2465030478","https://openalex.org/W2614362047","https://openalex.org/W3004266491","https://openalex.org/W4239471829"],"related_works":["https://openalex.org/W2048359154","https://openalex.org/W2084044006","https://openalex.org/W2401631784","https://openalex.org/W2019959763","https://openalex.org/W3019921907","https://openalex.org/W2184120063","https://openalex.org/W1992961115","https://openalex.org/W2549031161","https://openalex.org/W1988422655","https://openalex.org/W2752189600"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"review":[2],"the":[3,10,20,41,81,93,132,142,171,238,266,270,291,305],"clinical":[4,164,275],"and":[5,19,29,72,92,108,169,192,208,229,283],"economic":[6],"impact":[7,21,303],"of":[8,12,22,43,60,75,84,95,144,174,187,198,219,225,240,242,249,258,269,293,308],"atherothrombosis,":[9,18],"use":[11,94,173,257],"antiplatelet":[13],"therapy":[14],"for":[15,178,214,295],"patients":[16,119,243,296],"with":[17,244,297],"disease":[23,230],"management":[24,231],"programs":[25,158],"on":[26,46,273,304],"quality":[27,143,155,226,239,292,307],"improvement":[28,156,227],"health":[30,128,189,309],"care":[31,129,145,190,241,294,310],"costs.":[32,150,221,315],"SUMMARY:":[33],"Atherothrombosis":[34],"is":[35,80,252],"a":[36,44,57,185,215,301],"new":[37],"term":[38],"that":[39,116,159,195,279],"describes":[40],"formation":[42],"thrombus":[45],"an":[47],"existing":[48],"atherosclerotic":[49],"plaque.":[50],"While":[51],"simple,":[52],"this":[53,250],"pathophysiologic":[54],"mechanism":[55],"underlies":[56],"vast":[58],"array":[59],"vascular":[61,70],"diseases,":[62],"including":[63,166,265],"myocardial":[64],"infarction,":[65],"ischemia,":[66],"peripheral":[67],"arterial":[68],"disease,":[69],"death,":[71],"many":[73],"forms":[74],"stroke.":[76],"In":[77],"fact,":[78],"atherothrombosis":[79,298],"leading":[82],"cause":[83],"death":[85],"worldwide.":[86],"Treatment":[87],"approaches":[88,153],"include":[89],"lifestyle":[90],"modification":[91],"pharmacologic":[96,253],"agents":[97],"such":[98,205],"as":[99,206,311,313],"lipid-lowering":[100],"therapy,":[101,105],"antihypertensive":[102],"agents,":[103],"hypoglycemic":[104],"ACE":[106],"inhibitors,":[107],"beta-blockers.":[109],"Despite":[110],"these":[111,152],"treatments,":[112],"studies":[113],"have":[114,300],"indicated":[115],"not":[117],"all":[118],"receive":[120],"recommended":[121],"therapies.":[122],"The":[123,223,255],"continuing":[124],"upward":[125],"spiral":[126],"in":[127,131,290],"costs":[130],"United":[133],"States":[134],"has":[135],"spurred":[136],"numerous":[137],"initiatives":[138],"aimed":[139],"at":[140],"improving":[141],"while":[146],"maintaining":[147],"or":[148],"reducing":[149],"Among":[151],"to":[154,162,236,286],"are":[157,181],"promote":[160],"adherence":[161],"evidence-based":[163],"data,":[165],"published":[167],"guidelines,":[168],"improve":[170,237],"appropriate":[172,256],"pharmaceuticals.":[175],"Although":[176],"expenditures":[177],"prescription":[179,259],"drugs":[180,260],"rising,":[182],"they":[183],"remain":[184],"minority":[186],"overall":[188,306],"expenditures,":[191],"evidence":[193],"suggests":[194],"improved":[196],"usage":[197],"medications":[199],"can":[200,233,299],"reduce":[201],"other":[202],"direct":[203],"costs,":[204],"hospitalizations":[207],"inpatient":[209],"care,":[210],"which":[211],"may":[212],"account":[213],"far":[216],"greater":[217],"proportion":[218],"total":[220,314],"CONCLUSION:":[222],"utilization":[224],"techniques":[228],"tools":[232],"be":[234],"used":[235],"atherothrombosis.":[245],"A":[246],"key":[247,263],"component":[248],"strategy":[251],"therapy.":[254],"involves":[261],"several":[262],"factors,":[264],"proper":[267],"selection":[268],"agent":[271],"based":[272],"available":[274],"evidence,":[276],"choosing":[277],"regimens":[278],"enhance":[280],"patient":[281],"compliance,":[282],"sound":[284],"methodologies":[285],"evaluate":[287],"outcomes.":[288],"Improvements":[289],"significant":[302],"well":[312]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}